Donald L Kreutzer

USPTO Granted Patents = 11 (Patent Applications = 5)

CIPO Patents = 1 (Patent Applications = 4)

EPO Patents = 2 (Patent Applications = 4)

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 472(Granted Patents)

Company Filing History:

7 out of 7

Cell and Molecular Tissue Engineering, LLC

patents

3 out of 759

University of Connecticut

patents

1 out of 539

Hoechst Roussel Pharmaceuticals

patents

Years Active: 1987-2024

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12109252 - Systems, methods and products for minimizing tissue reactions and tissue injury at an infusion site (2024-10-08),

2. 11554160 - Systems, methods and products for minimizing tissue reactions and tissue injury at an infusion site (2023-01-17),

3. 11491001 - Implantable devices coated with extracellular matrix (2022-11-08),

4. 10821156 - Systems, methods and products for minimizing tissue reactions and tissue injury at an infusion site (2020-11-03),

5. 10405961 - Coated surgical mesh, and corresponding systems and methods (2019-09-10),

6. 10130288 - Coated sensors, and corresponding systems and methods (2018-11-20),

7. 9717583 - Sensors, cannulas, collars and coated surgical mesh, and corresponding systems and methods (2017-08-01),

8. 9247910 - Artificial tissue systems and uses thereof (2016-02-02),

9. 8916184 - Artificial tissue systems and uses thereof (2014-12-23),

10. 6497729 - Implant coating for control of tissue/implant interactions (2002-12-24),

11. 4636507 - Host defense mechanism enhancement (1987-01-13),

Title: **Donald L. Kreutzer: Innovator in Tissue Engineering**

Introduction

Donald L. Kreutzer, hailing from Avon, CT, is a notable inventor recognized for his significant contributions to the field of tissue engineering. With an impressive portfolio of 11 patents, he has dedicated his career to advancing medical technologies that minimize tissue reactions and injuries associated with infusion sites.

Latest Patents

Among Kreutzer's latest innovations are systems, methods, and products aimed at minimizing tissue reactions related to intravenous insulin delivery. His groundbreaking patent discloses products and methods designed to reduce the concentrations of preservatives and fibrils in liquid insulin compositions. Notably, one method involves substituting phenol and m-cresol with alternatives such as cyclodextrins, cyclodextrin polymers, cyclodextrin beads, and ion exchange resins, showcasing Kreutzer's commitment to improving patient outcomes in diabetes management.

Career Highlights

Kreutzer's career includes significant positions at notable institutions, including Cell and Molecular Tissue Engineering, LLC and the University of Connecticut. His work at these organizations has played a crucial role in shaping innovative approaches to healthcare and medical device technology.

Collaborations

Throughout his career, Kreutzer has collaborated with esteemed colleagues such as Ulrike W. Klueh and David Isaac Dorsky. These partnerships have further expanded his influence in the field and contributed to the development of pivotal medical innovations.

Conclusion

Donald L. Kreutzer stands out as a dedicated inventor whose work has profoundly impacted the realm of tissue engineering and medical devices. His ongoing commitment to research and innovation continues to drive advancements that enhance patient care and medical practices.

This text is generated by artificial intelligence and may not be accurate.